Holen Sie sich die Stockscreener-App
148.83
0.15%
-0.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$149.06
Offen:
$149.42
24-Stunden-Volumen:
966.21K
Relative Volume:
0.58
Marktkapitalisierung:
$13.75B
Einnahmen:
$20.97B
Nettoeinkommen (Verlust:
$3.13B
KGV:
4.7687
EPS:
31.21
Netto-Cashflow:
$2.39B
1W Leistung:
+0.54%
1M Leistung:
+13.55%
6M Leistung:
-9.91%
1J Leistung:
+16.56%
1-Tages-Spanne:
$147.51
$151.44
1-Wochen-Bereich:
$146.31
$153.00
52-Wochen-Spanne:
$109.82
$171.20
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Vergleichen Sie THC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
148.83 | 13.75B | 20.97B | 3.13B | 2.39B | 31.21 |
|
HCA
Hca Healthcare Inc
|
353.70 | 83.71B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.39 | 15.02B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
EHC
Encompass Health Corp
|
116.41 | 11.76B | 5.22B | 422.40M | 269.50M | 4.14 |
|
UHS
Universal Health Services Inc
|
181.78 | 11.65B | 15.42B | 1.03B | 956.84M | 15.02 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Tenet to Participate in BofA Securities 2025 Health Care Conference - Stock Titan
Tenet Healthcare Affirms FY09 Adj. EBITDA Outlook; Announces Private Offering of $450 Mln Senior Secured Notes due 2019Update - RTTNews
Tenet Healthcare Boosts FY09 ForecastUpdate - RTTNews
Tenet Healthcare Lifts Outlook On Cost Efficiencies - RTTNews
Tenet Healthcare Q2 Loss Widens, Lowers Full-year Outlook - RTTNews
Tenet Healthcare Posts Loss - RTTNews
Feds Join Whistleblower Suit Against Tenet Healthcare - RTTNews
Tenet hospitals sue Leapfrog Group over 'pay-to-play' grades - Modern Healthcare
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock - Yahoo Finance
Goldman Sachs Raises Price Target for Tenet Healthcare (THC) | THC Stock News - GuruFocus
THC Stock Update: Morgan Stanley Raises Price Target for Tenet Healthcare | THC Stock News - GuruFocus
Goldman Sachs lifts Tenet Healthcare target to $154, keeps neutral stance - Investing.com
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? - Benzinga
If You Invested $1000 in Tenet Healthcare a Decade Ago, This is How Much It'd Be Worth Now - MSN
Mass. DPH deems Framingham Union maternity services necessary. What happens next - MetroWest Daily News
Tenet Beats Q1 Earnings on Strong Ambulatory Unit, Ups '25 EPS View - MSN
South Florida hospitals say patient safety rankings are rigged, and sue nonprofit - Miami Herald
Tenet Healthcare gains after Q1 beat - MSN
3 DMC hospitals receive failing safety grades as Tenet reports $406M profit - Crain's Detroit Business
Tenet Healthcare Shines With Impressive Q1 Performance - Finimize
Tenet Beats Q1 Earnings On Strong Ambulatory Unit, Ups '25 EPS View - Barchart.com
RBC Capital Increases Price Target for Tenet Healthcare (THC) Am - GuruFocus
Cantor Fitzgerald holds Tenet Healthcare stock at Overweight, $177 target - Investing.com
Tenet Healthcare (THC) Receives Price Target Increase from UBS | - GuruFocus
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term - Yahoo
Guggenheim Increases Price Target for Tenet Healthcare (THC) to $180 | THC Stock News - GuruFocus
Tenet Healthcare Corporation (NYSE:THC) Q1 2025 Earnings Call Transcript - Insider Monkey
Tenet Healthcare (THC) Price Target Raised by Barclays | THC Sto - GuruFocus
Tenet Healthcare Corp (THC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Tenet Healthcare Reports Strong Q1 2025 Results - TipRanks
Tenet Healthcare Corp (THC) Q1 2025 Earnings Call Highlights: St - GuruFocus
Tenet Healthcare (THC) Surges on Strong Q1 2025 Performance - GuruFocus
Tenet Healthcare’s Strong Q1 Performance Amid Policy Uncertainty - TipRanks
Tenet Healthcare Q1 2025 presentation: EBITDA jumps 14%, USPI expansion continues - Investing.com
Earnings call transcript: Tenet Healthcare Q1 2025 beats EPS forecast, stock up 7.74% - Investing.com
Tenet: Q1 Earnings Snapshot - San Antonio Express-News
Tenet Healthcare (THC) Reports Strong Q1 2025 Results and Confir - GuruFocus
Tenet Healthcare (THC) Exceeds Q1 Revenue Expectations with $5.22B | THC Stock News - GuruFocus
U.S. Markets Moved Upward Tuesday; Tenet Healthcare Led Increases - Barron's
Tenet Healthcare (THC) Beats Q1 Earnings Estimates - GuruFocus
Why Is Tenet Healthcare (THC) Stock Soaring Today - Barchart.com
Tenet Earnings: Elevated Medical Utilization Reinforces 2025 Guidance - Morningstar
Tenet Healthcare earnings beat by $1.19, revenue topped estimates - Investing.com
Tenet Healthcare (THC) Exceeds Q1 Revenue Expectations with $5.2 - GuruFocus
Tenet Healthcare (THC) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Tenet Healthcare stock rises as Q1 earnings surpass expectations By Investing.com - Investing.com Canada
Tenet Healthcare stock rises as Q1 earnings surpass expectations - Investing.com
Tenet Healthcare (NYSE:THC) Surprises With Q1 Sales - Yahoo
Tenet Healthcare Corporation Q1 2025 Financial Results - TradingView
Tenet Healthcare Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):